Morgan Stanley’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $44.3K | Sell |
|
|||||
|
2023
Q2 | $14.2K | Hold |
|
|||||
|
2023
Q1 | $18.8K | Sell |
|
|||||
|
2022
Q4 | $25.2K | Buy |
|
|||||
|
2022
Q3 | $25K | Sell |
|
|||||
|
2022
Q2 | $41K | Sell |
|
|||||
|
2022
Q1 | $75K | Sell |
|
|||||
|
2021
Q4 | $284K | Sell |
|
|||||
|
2021
Q3 | $456K | Sell |
|
|||||
|
2021
Q2 | $1.47M | Buy |
|
|||||
|
2021
Q1 | $321K | Buy |
|
|||||
|
2020
Q4 | $47K | Sell |
|
|||||
|
2020
Q3 | $55K | Sell |
|
|||||
|
2020
Q2 | $81K | Sell |
|
|||||
|
2020
Q1 | $98K | Sell |
|
|||||
|
2019
Q4 | $2.7M | Buy |
|
|||||
|
2019
Q3 | $1.09M | Buy |
|
|||||
|
2019
Q2 | $1.75M | Buy |
|
|||||
|
2019
Q1 | $555K | Buy |
|
|||||
|
2018
Q4 | $28K | Sell |
|
|||||
|
2018
Q3 | $121K | Sell |
|
|||||
|
2018
Q2 | $651K | Buy |
|
|||||
|
2018
Q1 | $551K | Sell |
|
|||||
|
2017
Q4 | $3.13M | Buy |
|
|||||
|
2017
Q3 | $780K | Buy |
|
|||||
|
2017
Q2 | $660K | Sell |
|
|||||
|
2017
Q1 | $1.16M | Buy |
|
|||||
|
2016
Q4 | $281K | Buy |
|
|||||
|
2016
Q3 | $233K | Buy |
|
|||||
|
2016
Q2 | $70K | Buy |
|
|||||
|
2016
Q1 | $33K | Buy |
|
|||||
|
2015
Q4 | $34K | Sell |
|
|||||
|
2015
Q3 | $143K | Buy |
|